Annals of the Rheumatic Diseases

Visão geral
Metrics
Identidade
Ver todos

Qualis

A1

código do país

GB

tipo

journal

publicação venue de

AB0315-ESTABLISHED RHEUMATOID ARTHRITIS PATIENTS APPEAR TO HAVE IMPAIRED QUADRICEPS MUSCLE MORPHOLOGY ASSESSED BY ULTRASOUND AND MUSCLE STRENGTH IMPAIRED OVER TIME: A COHORT STUDY. 82:1341-1341. 2023-01-01
AB0428-SAFETY AND PERSISTENCE OF TREATMENT WITH GOLIMUMAB VERSUS CERTOLIZUMAB IN RHEUMATOID ARTHRITIS: RESULTS FROM BIOBADABRASIL COHORT STUDY.. 82:1402.2-1403. 2023-01-01
AB1655-PREVALENCE OF COMORBIDITIES IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND AXIAL SPONDYLARTHRITIS: RESULTS OF AN INTERNATIONAL, REAL WORLD PANLAR´S REGISTER. 82:2063.2-2063. 2023-01-01
Benefits of physiotherapy resources in fibromyalgia. 82:1921. 2023-01-01
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. 2:ard-2022-223499. 2023-01-01
OP0223-THE EFFECT OF ANTIMALARIALS ON THE RISK AND SEVERITY OF BACTERIAL, VIRAL, FUNGAL AND SYSTEMIC-SPECIFIC INFECTIONS IN RHEUMATOID ARTHRITIS. 82:147.1-147. 2023-01-01
POS0055-BEYOND THE WINDOW: EFFECTS OF LONG-TERM TIGHT CONTROL IN EARLY-TREATED RHEUMATOID ARTHRITIS UNDER REAL-LIFE CONDITIONS. 82:237.2-238. 2023-01-01
POS0469-BEHOLD THE WINDOW, MIND THE BUILDING! LONG-TERM BENEFITS FROM EARLY RHEUMATOID ARTHRITIS TREATMENT VANISHED UNDER REAL-LIFE CONDITIONS: RESULTS FROM THE REAL STUDY. 82:493-494. 2023-01-01
POS0534-PREDICTORS OF SERIOUS INFECTIONS IN RHEUMATOID ARTHRITIS - A PROSPECTIVE BRAZILIAN COHORT. 82:530.1-531. 2023-01-01
POS0744-MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN ACROSS 16 LATIN AMERICAN COUNTRIES: A MULTICENTER STUDY FROM THE REKAMLATINA NETWORK. 82:662-663. 2023-01-01
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. 000:ard-2022-223328-000. 2023-01-01
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica. 1:ard-2022-223429. 2023-01-01
AB0051-EVIDENCE OF VERY EARLY CARTILAGE DAMAGE IN EXPERIMENTAL OSTEOARTHRITIS USING SCANNING ELECTRON MICROSCOPY. 81:1160.1-1160. 2022-01-01
AB0173-MORPHOLOGICAL PARAMETERS ASSESSED BY ULTRASOUND IN QUADRICEPS MUSCLE WERE ASSOCIATED WITH CLINICAL FEATURES, MUSCLE STRENGTH, FUNCTIONAL CAPACITY AND PHYSICAL FUNCTION OF RHEUMATOID ARTHRITIS PATIENTS. 81:1216.1-1216. 2022-01-01
AB0905-Routine Assessment of Patient Index Data 3 (RAPID3) in Patients With Active Psoriatic Arthritis (PsA) After Inadequate Response or Intolerance to DMARDs: Pooled Results From the Phase 3, Randomized, Double-Blind KEEPsAKE 1 and 2 Trials. 81:1582-1582. 2022-01-01
AB1173-INCIDENT CASES OF COVID-19 AND VACCINATION ADHERENCE IN A MULTICENTRIC COHORT OF INFLAMMATORY ARTHRITIS IN BRAZIL. 81:1701.3-1702. 2022-01-01
AB1533-HPR-ASSOCIATED FACTORS OF FALL OR FRACTURE REPORTED BY RHEUMATOID ARTHRITIS PATIENTS IN ELECTRONIC MDHAQ DURING COVID-19 PANDEMIC. 81:1868.2-1869. 2022-01-01
AB1538-HPR-AMIGOS DE FIBRO (FIBRO FRIENDS): VALIDATION OF AN EDUCATIONAL PROGRAM TO PROMOTE THE HEALTH OF PATIENTS WITH FIBROMYALGIA IN BRAZIL.. 81:1871-1871. 2022-01-01
AB1539-HPR-AMIGOS DE FIBRO (FIBRO FRIENDS): VALIDATION OF AN EDUCATIONAL E-BOOK TO PROMOTE THE HEALTH OF PEOPLE LIVING WITH FIBROMYALGIA IN BRAZIL. 81:1871-1871. 2022-01-01
Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports. 1:annrheumdis-2022-222505. 2022-01-01
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. 00:970-9. 2022-01-01
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. 02:710-719. 2022-01-01
Gain-of-function mutations in cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome. online:annrheumdis-2022-222629. 2022-01-01
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. 03:1036-1-8. 2022-01-01
OP0057-RESPONSE TO INJECTION CAN PREDICT OUTCOMES OF FEMOROACETABULAR IMPINGEMENT. 81:38.1-38. 2022-01-01
POS0242-THE EFFECT OF ANTIMALARIALS ON THE OVERALL SAFETY AND PERSISTENCE OF TREATMENT WITH BIOLOGIC AGENTS OR JAK INHIBITORS IN RHEUMATOID ARTHRITIS. 81:360.2-361. 2022-01-01
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. 03:889-897. 2022-01-01
AB0288-SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: YEAR 2 FOLLOW-UP OF A LARGE PHASE 4, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY. 80:1170-1171. 2021-01-01
AB0457-HIPPOCAMPAL SUBFIELDS VOLUMES REDUCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS: A LONGITUDINAL MAGNETIC RESONANCE IMAGING (MRI) VOLUMETRIC STUDY. 80:1255.2-1256. 2021-01-01
AB0754-THE INFLUENCE OF PHYSICAL ACTIVITY ON BODY COMPOSITION AND SELF-ESTEEM IN ADULTS WITH JUVENIL IDIOPATHIC ARTHRITIS. 80:1405.1-1405. 2021-01-01
AB0798-IS THERE A REPRODUCIBILITY OF THE HISTOGRAM AND GRAY SCALE IN ECOEXTRUCTURAL DAMAGES IN RHEUMATOTOLOGICAL DISEASES?. 80:1423.2-1424. 2021-01-01
AB0848 PARTICIPATION OF UNDERGRADUATE MEDICAL STUDENTS AS INVESTIGATORS IN A RHEUMATOLOGIC COHORT: IMPACT ON DEPRESSION, ANXIETY & STRESS SCALE. .:.-1448. 2021-01-01
AB0878-HPR-EFFECT OF AQUATIC PHYSIOTHERAPY ON PAIN AND QUALITY OF LIFE IN ELDERLY WOMEN WITH FIBROMYALGIA. 80:1462.2-1462. 2021-01-01
AB0912-HPR¿AMIGOS DE FIBRO (FIBRO FRIENDS): EDUCATIONAL PROGRAM TO PROMOTE THE HEALTH OF PEOPLE WITH FIBROMYALGIA IN BRAZIL. 80:1478.1-1478. 2021-01-01
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. 1:annrheumdis-20-10. 2021-01-01
Correspondence on ?Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine? - Increase in the number of systemic lupus erythematosus cases in Brazil in the COVID-19 Era. 2021:1-2. 2021-01-01
Correspondence on ?Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine? by Mathian et al; Increase in the number of systemic lupus erythematosus cases in Brazil in the COVID-19 era. 1:1-2. 2021-01-01
Flares after hydroxychloroquine reduction or discontinuation: Results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. 80:1-9. 2021-01-01
Increase in the number of systemic lupus erythematosus cases in Brazil in the COVID-19 Era.. 80:iiii. 2021-01-01
POS0013-MUSCULOSKELETAL MANIFESTATIONS IN PATIENTS WITH ENDOCRINE DISEASES IN TERTIARY SERVICE. 80:208.1-208. 2021-01-01
POS0316-MODELLING SHORT-TERM FVC CHANGES FROM SENSCIS TO LONG-TERM FVC COURSE IN SSc-ILD DEMONSTRATES CLINICALLY MEANINGFUL REDUCTION OF FVC DECLINE AND SURVIVAL BENEFITS. 80:384-385. 2021-01-01
POS0676-SURVIVAL OF THE FIRST COURSE OF BIOLOGIC OR JAK INHIBITOR IN RHEUMATOID ARTHRITIS: ASSOCIATION WITH THE CHOICE OF AGENT AND CONCOMITANT CONVENTIONAL SYNTHETIC DMARDS. 80:582.2-583. 2021-01-01
POS0747-MAPPING THE NATIONWIDE CLINICAL PROFILE AND PATTERNS OF CARE OF SLE IN BRAZIL - FINDINGS FROM THE MACUNAÍMA STUDY. 80:625.2-626. 2021-01-01
POS0887-TRANSCRANIAL ELECTRICAL STIMULATION IS SAFE AND EFFICIENT IN PATIENTS WITH SYSTEMIC AUTOIMMUNE MYOPATHIES. 80:699.2-700. 2021-01-01
POS1252-COVID-19 IN PATIENTS WITH RHEUMATIC DISEASES ON CHRONIC USE OF HYDROXYCHLOROQUINE IN A LARGE BRAZILIAN COHORT - A 24-WEEK PROSPECTIVE STUDY. 80:909-910. 2021-01-01
POS1430-EPIDEMIOLOGY OF LUPUS NEPHRITIS IN BRAZIL: FINDINGS FROM THE MACUNAÍMA STUDY - A NATIONWIDE MULTICENTRIC STUDY. 80:999.1-999. 2021-01-01
AB1319-HPR-EFFECT OF SEGMENTAL STABILIZATION AND PILATES ON CHRONIC NON-SPECIFIC LOW BACK PAIN: PILOT STUDY. 79:1949.1-1949. 2020-01-01
ANTINOCICEPTIVE EFFECT OF Α-PHELLANDRENE IN CHRONIC PAIN: IN SILICO PHARMACOKINETIC, MOLECULAR DOCKING AND IN VIVO EVALUATION. 79:459. 2020-01-01
Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever. -:annrheumdis-2019-216701. 2020-01-01
COVID-19 in patients with rheumatic diseases: what is the real mortality risk?. 1:annrheumdis-20-1. 2020-01-01
COVID-19 in patients with rheumatological diseases treated with anti-TNF. 00:annrheumdis-2020-218171-2. 2020-01-01
Correspondence on `Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial?. 999:annrheumdis-2020-218911. 2020-01-01
DAPSA versus cDAPSA: Do we need to use CRP?. 79:e142-e142. 2020-01-01
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. 79:193-201. 2020-01-01
Does hydroxychloroquine prevent the transmission of covid-19?. 79:annrheumdis-20-0. 2020-01-01
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. 79:3-18. 2020-01-01
FRI0332-EVALUATION OF THE INDIVIDUAL COMPONENTS OF ACR50+PASI100 AND MDA AT WEEK 24 FROM THE SPIRIT-H2H TRIAL COMPARING THE EFFICACY AND SAFETY OF IXE VERSUS ADA IN PATIENTS WITH PSA NAÏVE TO BDMARDS. 79:758.1-758. 2020-01-01
LRBA deficiency: a new genetic cause of monogenic lupus. 79:427-428. 2020-01-01
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. 1:annrheumdis-2020-218398. 2020-01-01
SAT0345-IS THERE A DIFFERENCE BETWEEN THE SEXES IN THE RATE OF PROGRESSION OF SYSTEMIC SCLEROSIS-ASSOCIATED ILD (SSC-ILD)? DATA FROM THE SENSCIS TRIAL. 79:1118-1119. 2020-01-01
Steroid-resistant sarcoidosis treated with baricitinib. 79:1259-1260. 2020-01-01
Tackling osteoarthritis during COVID-19 pandemic. 80:annrheumdis-2020-218372. 2020-01-01

tem uma área de assunto

publisher

BMJ

is open access

False invalid format

is in DOAJ

False invalid format